A selective policy in follow-up for bowel cancer

Lancet. 1998 Jun 20;351(9119):1891-2. doi: 10.1016/S0140-6736(05)78846-2.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Aftercare / methods*
  • Antineoplastic Agents / therapeutic use*
  • Colorectal Neoplasms / drug therapy*
  • Humans
  • Neoplasm Recurrence, Local / drug therapy*
  • Palliative Care / methods*
  • Survival Analysis
  • Time Factors

Substances

  • Antineoplastic Agents